BRIGHT MINDS BIOSCIENCES INC.
For the period ended Mar 31, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Mar 31, 2026 · Filed May 20, 2026
Use the contents to explore the available documents and sections.
DRUG$23.00+11.1%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Ability to continue as a going concern
Ability to continue as a going concern
Evaluation of the ability of the Company to realize its strategy for funding its future needs for working capital involves making judgments.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.